ZA200904530B - Solid of macrolide compound, method for production thereof, and pharmaceutical composition comprising the same - Google Patents
Solid of macrolide compound, method for production thereof, and pharmaceutical composition comprising the sameInfo
- Publication number
- ZA200904530B ZA200904530B ZA200904530A ZA200904530A ZA200904530B ZA 200904530 B ZA200904530 B ZA 200904530B ZA 200904530 A ZA200904530 A ZA 200904530A ZA 200904530 A ZA200904530 A ZA 200904530A ZA 200904530 B ZA200904530 B ZA 200904530B
- Authority
- ZA
- South Africa
- Prior art keywords
- solid
- production
- pharmaceutical composition
- same
- macrolide compound
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000003120 macrolide antibiotic agent Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007017491 | 2007-01-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200904530B true ZA200904530B (en) | 2010-09-29 |
Family
ID=39674155
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200904530A ZA200904530B (en) | 2007-01-29 | 2008-01-28 | Solid of macrolide compound, method for production thereof, and pharmaceutical composition comprising the same |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7790887B2 (fr) |
| EP (1) | EP2116542A4 (fr) |
| JP (1) | JPWO2008093853A1 (fr) |
| KR (1) | KR20090104002A (fr) |
| CN (1) | CN101616912A (fr) |
| AR (1) | AR065045A1 (fr) |
| AU (1) | AU2008211950A1 (fr) |
| BR (1) | BRPI0805837A2 (fr) |
| CA (1) | CA2673734A1 (fr) |
| CL (1) | CL2008000231A1 (fr) |
| IL (1) | IL200103A0 (fr) |
| MX (1) | MX2009008068A (fr) |
| NZ (1) | NZ575828A (fr) |
| PE (1) | PE20081705A1 (fr) |
| RU (1) | RU2009132476A (fr) |
| WO (1) | WO2008093853A1 (fr) |
| ZA (1) | ZA200904530B (fr) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI334866B (en) * | 2002-05-29 | 2010-12-21 | Mercian Corp | Novel physiologically active substances |
| BRPI0805837A2 (pt) | 2007-01-29 | 2011-08-30 | Eisai R&D Man Co Ltd | forma sólida de um composto, método para preparação dos cristais, composição farmacêutica, método de tratamento de cáncer, e uso do composto sólido |
| EP2168961A1 (fr) * | 2007-07-06 | 2010-03-31 | Eisai R&D Management Co., Ltd. | Procédé de fabrication d'un composé macrolide et intermédiaire |
| IL303335B1 (en) | 2018-04-09 | 2024-09-01 | Eisai R&D Man Co Ltd | Palladianolide compounds and their use |
| TWI834655B (zh) | 2018-04-12 | 2024-03-11 | 日商衛材R&D企管股份有限公司 | 特定芳基普拉二烯內酯化合物及其使用方法 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL27183A (en) | 1966-02-01 | 1970-07-19 | Upjohn Co | Parenteral composition comprising freeze dried mannitol |
| JPS6054933B2 (ja) | 1978-01-27 | 1985-12-03 | 小野薬品工業株式会社 | プロスタグランジン及びプロスタグランジン類似化合物製剤の安定化法 |
| JPH04352783A (ja) | 1991-05-27 | 1992-12-07 | Taisho Pharmaceut Co Ltd | １２員環マクロライド系化合物 |
| PL316995A1 (en) | 1994-04-25 | 1997-03-03 | Kyowa Hakko Kogyo Kk | Method of stabilising the dx-52-1 compound and freeze dried compositions thereof |
| EP1192147A1 (fr) | 1999-06-03 | 2002-04-03 | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Mycolactone et composes et compositions qui y sont lies ainsi que procedes d'utilisation correspondants |
| US6391903B1 (en) | 1999-09-09 | 2002-05-21 | Sankyo Company, Limited | Triazole derivatives having antifungal activity |
| JP3240129B1 (ja) * | 1999-09-09 | 2001-12-17 | 三共株式会社 | トリアゾール抗真菌剤 |
| JP4953501B2 (ja) * | 1999-09-30 | 2012-06-13 | 大塚化学株式会社 | ３−セフェム誘導体結晶の製造方法 |
| AU2001278155A1 (en) | 2000-08-03 | 2002-02-18 | Kosan Biosciences, Inc. | Fermentation and purification of mycolactones |
| TWI311558B (en) | 2001-02-01 | 2009-07-01 | Mercian Corporatio | Novel physiologically active substance |
| TWI233361B (en) | 2001-04-13 | 2005-06-01 | Gen Hospital Corp | Methods of preventing UVB-induced skin damage |
| TWI334866B (en) | 2002-05-29 | 2010-12-21 | Mercian Corp | Novel physiologically active substances |
| JP2004269488A (ja) | 2002-06-06 | 2004-09-30 | Hayashibara Biochem Lab Inc | 結晶α−Ｄ−グルコシルα−Ｄ−ガラクトシドとこれを含有する糖質及びこれらの製造方法並びに用途 |
| BR0313039A (pt) | 2002-07-31 | 2005-08-09 | Mercian Corp | Composto, medicamento, composição farmacêutica, método para prevenir ou tratar uma doença contra a qual um controle da expressão do gene é eficaz, método para prevenir ou tratar uma doença contra a qual a supressão da produção de vegf é eficaz, método para prevenir ou tratar uma doença contra a qual uma inibição da angiogênese é eficaz, uso do composto, método para produzir um composto 9-desoxi 1107, linhagem streptomyces sp. a-1543 (ferm bp-8442), método de produzir um composto 6- desoxi, e linhagem a-1544 (ferm bp-8446) ou linhagem a-1545 (ferm bp-8447) |
| US7576204B2 (en) | 2002-07-31 | 2009-08-18 | Mercian Corporation | Heterocyclic macrolide pharmaceutical agent, a method of producing the same and use of the same |
| CA2507641A1 (fr) | 2002-11-29 | 2004-06-17 | Mercian Corporation | Procede de production d'un compose macrolide |
| KR100732100B1 (ko) | 2003-05-07 | 2007-06-27 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 메틸코발라민 함유 동결 건조 제제 및 그의 제조 방법 |
| CA2553573A1 (fr) | 2004-01-29 | 2005-08-11 | Eisai R & D Management Co., Ltd. | Methode de stabilisation d'un compose de macrolide |
| US20080280288A1 (en) * | 2004-02-06 | 2008-11-13 | Toshimitsu Uenaka | Assay Method to Predict Sensitivity of Cancer Cell to Anticancer Drug |
| JP2007269628A (ja) * | 2004-05-28 | 2007-10-18 | Takeda Chem Ind Ltd | 医薬化合物の結晶 |
| JP2007519758A (ja) * | 2004-12-01 | 2007-07-19 | テバ ジョジセルジャール ザ−トケルエン ムケド レ−スベニュタ−ルシャシャ−グ | 結晶マクロライドの生成方法 |
| KR100598119B1 (ko) | 2005-01-17 | 2006-07-10 | 삼성전자주식회사 | 디스플레이장치 및 그 제어방법 |
| CA2607639A1 (fr) | 2005-05-11 | 2006-11-16 | Eisai R & D Management Co., Ltd. | Cristal de derive d'indole comportant un cycle piperidine et procede de synthese dudit cristal |
| EP1935893A4 (fr) | 2005-10-13 | 2009-07-22 | Eisai R&D Man Co Ltd | Synthèse totale de pladienolide b et de pladienolide d |
| CA2659562A1 (fr) | 2006-08-14 | 2008-02-21 | Eisai R&D Management Co., Ltd. | Preparation lyophilisee stable |
| BRPI0805837A2 (pt) | 2007-01-29 | 2011-08-30 | Eisai R&D Man Co Ltd | forma sólida de um composto, método para preparação dos cristais, composição farmacêutica, método de tratamento de cáncer, e uso do composto sólido |
-
2008
- 2008-01-28 BR BRPI0805837-7A patent/BRPI0805837A2/pt not_active IP Right Cessation
- 2008-01-28 JP JP2008556207A patent/JPWO2008093853A1/ja not_active Withdrawn
- 2008-01-28 AR ARP080100323A patent/AR065045A1/es unknown
- 2008-01-28 AU AU2008211950A patent/AU2008211950A1/en not_active Withdrawn
- 2008-01-28 PE PE2008000198A patent/PE20081705A1/es not_active Application Discontinuation
- 2008-01-28 NZ NZ575828A patent/NZ575828A/en unknown
- 2008-01-28 MX MX2009008068A patent/MX2009008068A/es not_active Application Discontinuation
- 2008-01-28 RU RU2009132476/04A patent/RU2009132476A/ru not_active Application Discontinuation
- 2008-01-28 KR KR1020097012762A patent/KR20090104002A/ko not_active Application Discontinuation
- 2008-01-28 US US12/021,184 patent/US7790887B2/en not_active Expired - Fee Related
- 2008-01-28 ZA ZA200904530A patent/ZA200904530B/xx unknown
- 2008-01-28 CA CA002673734A patent/CA2673734A1/fr not_active Abandoned
- 2008-01-28 CN CN200880003310A patent/CN101616912A/zh active Pending
- 2008-01-28 CL CL200800231A patent/CL2008000231A1/es unknown
- 2008-01-28 WO PCT/JP2008/051695 patent/WO2008093853A1/fr active Application Filing
- 2008-01-28 EP EP08704375A patent/EP2116542A4/fr not_active Withdrawn
-
2009
- 2009-07-28 IL IL200103A patent/IL200103A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2008093853A1 (ja) | 2010-05-20 |
| CL2008000231A1 (es) | 2008-05-30 |
| EP2116542A1 (fr) | 2009-11-11 |
| US7790887B2 (en) | 2010-09-07 |
| BRPI0805837A2 (pt) | 2011-08-30 |
| EP2116542A4 (fr) | 2011-05-04 |
| CN101616912A (zh) | 2009-12-30 |
| AR065045A1 (es) | 2009-05-13 |
| IL200103A0 (en) | 2010-04-15 |
| KR20090104002A (ko) | 2009-10-05 |
| US20080214564A1 (en) | 2008-09-04 |
| PE20081705A1 (es) | 2008-12-22 |
| NZ575828A (en) | 2011-04-29 |
| CA2673734A1 (fr) | 2008-08-07 |
| RU2009132476A (ru) | 2011-03-10 |
| AU2008211950A1 (en) | 2008-08-07 |
| WO2008093853A1 (fr) | 2008-08-07 |
| MX2009008068A (es) | 2009-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2251038A4 (fr) | Dispersion solide, compositions pharmaceutiques comprenant celle-ci, et procédés de production associés | |
| IL196527A (en) | The history of the terroir is preserved, their processes and their use | |
| IL216171A (en) | Lipidic Compound, Method for Preparing the Compound, Pharmaceutical and Lipid Preparations Containing Their Composition and Uses | |
| EP2429987A4 (fr) | Composé amide, procédé de préparation de celui-ci et composition pharmaceutique le comprenant | |
| EP2109447A4 (fr) | Diamide acétate n, n- diméthyl imidodicarbonimidique, son procédé de production et compositions pharmaceutiques le comprenant | |
| IL208203A (en) | Annotations of 3,2-Dihydro-Pyrido-4,1-Exazine and 3,2-Dihydro-4-Oxa-9,1-Diazapananthrene, Preparation Processes and Pharmaceutical Preparations | |
| IL193772A0 (en) | 4-oxoquinoline derivatives,methods for the preparation thereof and pharmaceutical compositions containing the same | |
| EP1938842A4 (fr) | Procédé de préparation de composition pharmaceutique ayant une meilleure capacite de désintégration | |
| IL205073A (en) | 2 bst antibodies, methods of making them, medicinal preparations containing them and their use | |
| EP2199402A4 (fr) | Cycloastragénol monoglycoside, sa préparation, composition pharmaceutique le contenant et son utilisation | |
| EP2351764A4 (fr) | Composé de tréhalose, son procédé de fabrication et produit pharmaceutique contenant le composé | |
| EP2206429A4 (fr) | Composition antibiotique et procédé de production de celle-ci | |
| EP2394993A4 (fr) | Nouveau dérivé 3-nitropyridine substituée en 2,6, procédé de préparation de ce composé et composition pharmaceutique comprenant ce composé | |
| SI2231598T1 (sl) | Novi derivati diazeniumdiolata postopek pripravele teh in njihovi farmacevtski sestavki | |
| EP2141229A4 (fr) | Préparation pulvérulente de lipase, procédé de fabrication de celle-ci et son utilisation | |
| IL203064B (en) | A pharmaceutical preparation containing compound 11 - deoxy - prostaglandin and a method for stabilizing the compound | |
| ZA200904530B (en) | Solid of macrolide compound, method for production thereof, and pharmaceutical composition comprising the same | |
| EP2035406A4 (fr) | Nouveaux dérivés substitués de 1h-quinazoline-2,4-dione, procédé de préparation de ces derniers et composition pharmaceutique contenant lesdits dérivés | |
| HK1126190A1 (en) | Novel pyridinylaminoalkylene- and pyridinyloxyalkylene-cyclopropanamines, process for the preparation thereof and pharmaceutical compositions containing them | |
| EP2123662A4 (fr) | Composé tréhalose, procédé de fabrication du composé et agent immunostimulant comprenant le composé | |
| IL213792A0 (en) | Novel oxime derivatives of 3, 5-seco-4-nor-cholestane, pharmaceutical compositions containing the same and method for preparing the same | |
| EP2222624A4 (fr) | Dérivés de 4-nérolidylcatéchol, compositions pharmaceutiques comprenant ces dérivés et procédé de préparation de ceux-ci | |
| IL200951A0 (en) | Aryl-sulphonamid compounds, compositions comprising the same, processes for the preparation of the same and uses thereof | |
| IL192963A0 (en) | Rimonabant monohydrate, process for the preparation thereof and pharmaceutical compositions containing same | |
| ZA201003264B (en) | Method for the preparation of 2 chloro1,1,1,2,3,3,3 heptafluopropane |